An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer

Running, not enrolling · Not applicable

Conditions studied: Breast Carcinoma

In brief

This clinical trial examines a new imaging technology, contrast-enhanced mammography, in predicting breast cancer. Contrast-enhanced mammography is similar to standard mammography, but it includes an intravenous (by vein) injection of iodine-based contrast, which makes tissue and blood vessels more visible in scans. Contrast-enhanced mammography may work better in detecting cancer in the breast that is not seen on other imaging tests and may help doctors find the most suspicious areas of the breast to biopsy, which could increase the chances of finding breast cancer.

Key facts

Study ID
NCT04871139
Run by
M.D. Anderson Cancer Center
People needed
100
Starts
2021-04-08
Expected to finish
2028-03-01
Last updated by the study team
2026-03-27

Who can join

Age: 25 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.